A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate and compare the pharmacokinetics (blood levels) of 2
different formulations, assess the effect of food on the pharmacokinetics and assess safety
of rabeprazole sodium in healthy volunteers. Rabeprazole sodium is a drug used to treat
patients with Gastro Esophageal Reflux Disease (GERD). GERD is a condition in which the
esophagus (tube from throat to stomach) becomes irritated or inflamed because of acid backing
up from the stomach.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.